Report period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, $ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
IART:US | Integra LifeSciences Holdings Corp. | Common share | - | US4579852082 | $23.59 |
Company name | Integra LifeSciences Holdings |
---|---|
Sector | Health Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Supplies |
Business address | 311 ENTERPRISE DRIVE PLAINSBORO NJ 08536 6092750500 |
Mailing address | 311 ENTERPRISE DRIVE PLAINSBORO NJ 08536 |
Website | www.integralife.com |
Information disclosure | www.sec.gov |